[This review was originally posted at the Nieman Journalism Lab Buy Retin A No Prescription, on Aug. 12, 2011.]
Murdoch passes Wall Street's test: The fallout from News Corp.'s phone hacking scandal continued to spread this week, with the reported arrest of another former News of the World editor and the report that the ostensibly fired News Corp. British chief, Rebekah Brooks, Retin A alternatives, is still on the company payroll.
Three weeks after testifying before Parliament, Rupert Murdoch faced Wall Street analysts this week in a conference call, telling them that he's not going anywhere and that the scandal hasn't done any material damage to the company outside of News of the World. Purchase Retin A, All Things Digital's Peter Kafka said Wall Street really doesn't care about the hacking, and Murdoch didn't say much about the few questions he did get on it.
Murdoch also had to meet with News Corp.'s board, but as the New York Times' Jeremy Peters reported, the board's officially independent members include numerous people who have deep personal ties to Murdoch, Buy Retin A No Prescription. Perhaps more troubling was a different connection among one of the board members: According to Time's Massimo Calabresi, one of them is "best friends" with the district attorney leading the U.S. investigation into the company.
The Times' David Carr uncovered more hints at News Corp.'s enormous political influence here in the States, Retin A pics, detailing cases of swift approval of a merger by a Justice Department unit led by a future News Corp. executive, as well as a suspiciously dropped federal criminal case. "The company’s size and might give it a soft, less obvious power that it has been able to project to remarkable effect, Buy Retin A without prescription, " Carr concluded. Buy Retin A No Prescription, At Adweek, Murdoch biographer Michael Wolff went further, reporting that the Justice Department is considering investigating News Corp. on racketeering charges, though Forbes' Jeff Bercovici doubted that would happen. For a bit more info on the situation, here's a good Q&A with Nick Davies, the Guardian reporter who's been all over the story, order Retin A no prescription.
AOL's slap from investors: This week hasn't been a good one for AOL: After it reported a quarterly loss on Tuesday, its stock dropped by about a quarter by the end of the day. All Things Digital's Peter Kafka gave a quick explainer of why investors are so down on AOL: What little money they're making isn't coming from the all-important display advertising business. Mathew Ingram of GigaOM added more depth to that analysis, arguing that investors are doubting AOL's assurances that its two big gambles — Patch and the acquisition of the Huffington Post — will pay off, Buy Retin A No Prescription.
According to AOL CEO Tim Armstrong (paraphrased by Business Insider), Retin A price, coupon, the reason for those problems is that AOL's advertising side hasn't scaled well enough. Peter Kafka explained that AOL's advertising (especially display) is indeed up, though much of that can be attributed to the HuffPo and TechCrunch acquisitions. Forbes' Jeff Bercovici said AOL's public image problem has even damaged the previously successful HuffPo, quoting an analyst who called AOL a "dead brand." Wired's Tim Carmody decided to unite our two big stories this week and suggested that AOL would be a perfect fit for a purchase by News Corp.
Meanwhile's AOL's local-news initiative, Retin A samples, Patch, launched a Groupon-esque daily deal service, and Iowa grad student Robert Gutsche Jr.questioned Patch's standards for separating journalism and advertising — and got the runaround from Patch when he asked them about it. AOL's new daily tablet magazine, Editions, Buying Retin A online over the counter, also drew some criticism, with Fast Company's Austin Carr perturbed that it's not AOL-y enough.
A news org gets into tablets Buy Retin A No Prescription, : We've already seen numerous challengers to the iPad's early stranglehold on the tablet marketplace, but the Tribune Co. might be the first news company to try one out. CNN's Mark Milian reported that the newspaper chain is working on an Android-based tablet, which it's planning on offering it for free or very cheap to people who sign up for extended newspaper subscriptions. It's already missed a mid-August deadline for testing the tablet out, purchase Retin A online.
Media pundits didn't think much of the Tribune's idea. Wired's Tim Carmody urged the Tribune (and media companies in general) to quit developing tablets, arguing that it's way too hard to do if you're a major development company, let alone a news organization. "If major publishers are seriously prepared to blow up their primary revenue stream — print advertising — and slap together a giveaway tablet in order to save money on ink, God help them," he wrote, Buy Retin A No Prescription.
Others echoed Carmody's arguments: PaidContent's Tom Crazit called the project "a colossal waste of money for a company trying to emerge from bankruptcy." Chris Velazco of TechCrunch said the cheap-tablet model (also being talked about by Philadelphia Newspapers) isn't viable. Gizmodo's Brent Rose was less restrained: "WHY??" Morris Communications' Steve Yelvington was a little kinder to the Tribune, saying the numbers might add up, Kjøpe Retin A på nett, köpa Retin A online, but the devil's in the details.
The Times gets experimental: The New York Times has frequently made strong pushes into news innovation over the past several years, and this week it started another one, launching a new public test kitchen for projects in development. The Lab's Megan Garber explained what the site, beta620, Retin A for sale, is all about, but GigaOM's Mathew Ingram, while applauding the effort, expressed some doubt about whether the Times is really capable of developing a startup's mindset. Buy Retin A No Prescription, Tim Carmody of Wired, on the other hand, said the startup analogy isn't the right one for the Times. Retin A online cod, With these projects, he said, "The New York Times has become an openly experimental public institution. It’s less a cathedral consecrated to its own past than a free museum where patrons are invited to touch and transform everything they see." Poynter's Jeff Sonderman had some suggestions for next steps for the Times to take with beta620: experimenting with design, getting away from the long narrative article, and rethinking comments, Retin A trusted pharmacy reviews.
The real-name debate: One long-simmering debate I want to briefly catch you up on: Google+ has decided to take the Facebook route of disallowing pseudonyms, adjusting but reaffirming its policy in the face of online criticism late last month and again on Thursday. The outcry continued, voiced most prominently late last week by social media researcher danah boyd, Order Retin A from mexican pharmacy, who asserted that "'real names' policies aren’t empowering; they’re an authoritarian assertion of power over vulnerable people."
Liz Gannes of All Things Digital said she understands Google's motivations for enforcing real names and unifying everything under its umbrella within the same identity, but the idea of doing the latter is awkward at best and frightening at worst. The Atlantic's Alexis Madrigal, meanwhile, announced he's changed his mind against real-name policies, arguing that requiring real names online is a radical departure from the relationship between speech and identity in the offline world, Buy Retin A No Prescription.
Reading roundup: A few other things to keep an eye on this week:
— Amazon released a version of its Kindle app for browsers, called the Kindle Cloud Reader. GigaOM's Mathew Ingram said the browser-based e-book app (which bypasses Apple's restrictions) could be a roadmap for the future of the web, but Wired's Tim Carmody said it still doesn't get the web, Retin A without prescription.
— Google announced it's making its hand-chosen Editors' Picks a standing feature on Google News. The Lab's Megan Garber explained what Google's doing with it. Buy Retin A No Prescription, Meanwhile, James Gleick at The New York Review of Books offered a thoughtful piece on Google's domination of our online lives.
— Adweek explained an underrated obstacle to innovation and progress in news organizations' online efforts: the intractable CMS.
— Steve Buttry, now with the Journal Register Co., gave his lessons from TBD's demise on the Washington local news site's first birthday. It's short but solid. Enjoy.
Similar posts: Purchase Retin A. Order Cephalexin. Buy Zoloft No Prescription. Armour for sale. Where can i buy Cephalexin online. Synthroid without prescription.
Trackbacks from: Buy Retin A No Prescription. Buy Retin A No Prescription. Buy Retin A No Prescription. Retin A duration. Retin A images. Retin A australia, uk, us, usa.
[This review was originally posted at the Nieman Journalism Lab Purchase Diflucan, on Oct. 8, 2010.]
Another old-media stalwart goes online: This week's biggest story is a lot more interesting for media geeks than for those more on the tech side, but I think it does have some value as a sort of symbolic moment. Howard Kurtz, who's been The Washington Post's media writer for pretty much all of its recent history, jumped this week to The Daily Beast, Buy no prescription Diflucan online, an aggregation and news site run by former magazine star Tina Brown and media mogul Barry Diller. Kurtz will head the site's D.C. bureau and write about media and politics. He's about as traditional/insider Washington media as they come (he also hosts CNN's Reliable Sources), so seeing him move to an online-only operation that has little Beltway presence was surprising to a lot of media watchers.
So why'd he do it, Purchase Diflucan. In the announcement story at The Daily Beast, Kurtz said it was "the challenge of fast-paced online journalism" that drew him in. In interviews with TBD, Yahoo News and The New York Times, where can i find Diflucan online, Kurtz referred to himself as an "online entrepreneur" who hopes to find it easier to innovate at a two-year-old web publication than within a hulking institution like the Post. "If you want to get out there and invent something new, maybe it is better to try to do that at a young place that's still growing," he told TBD.
Kurtz has his critics, and while there are some (like the American Journalism Review's Rem Rieder) who saw this as a benchmark event for web journalism, Diflucan photos, several others didn't see The Daily Beast as the plucky, outsider startup Kurtz made it out to be. Purchase Diflucan, PaidContent's David Kaplan said that with folks like Brown and Diller involved, The Daily Beast has a lot of old media in its blood. (It may be partnered with Newsweek soon.) Salon's Alex Pareene made the point more sharply, saying he was going to work for his "rich friend's cheap-content farm" for a "fat check and a fancy title." As Rachel Sklar told Politico (in a much kinder take), for Kurtz, this is "risk, but padded risk."
Maybe the fact that this move isn't nearly as shockingly risky as it used to be is the main cultural shift we're seeing, argued Poynter's Steve Myers in the most thoughtful piece on this issue, buy Diflucan online cod. Kurtz is following a trail already blazed by innovators who have helped web journalism become financially mature enough to make this decision easy, Myers said. "Kurtz's move isn't risky or edgy; it's well-reasoned and practical -- which says more about the state of online media than it does about his own career path," Myers wrote. For his part, Kurtz said that his departure from the Post doesn't symbolize the death of print, but it does say something about the energy and excitement on the web. Get Diflucan, Of course, people immediately started drawing up lists of who should replace Kurtz at the Post, but the most worthwhile item on that front is the advice for Howard Kurtz's replacement by Clint Hendler of the Columbia Journalism Review. Hendler argued we'd be better off with a media critic than with another studiously balanced media writer, Purchase Diflucan. According to Hendler, that requires "someone who is willing to, as the case warrants, state opinions, poke fun, where can i order Diflucan without prescription, call sides, and make enemies."
A reporter and a newspaper chain's sad scandals: Two media scandals dominated the news about the news this week. First, Rick Sanchez up and got himself fired by CNN last Friday for a radio rant in which he called Jon Stewart a bigot and suggested that Jews run the news media and using it to keep him down. Sanchez apologized a few days later, and The Huffington Post's Chez Pazienza mined the incident for clues of what CNN/Rick Sanchez relations were like behind the scenes. Buy Diflucan from canada, There are a couple of minor angles to this that might interest future-of-news folks: Joe Gandelman at The Moderate Voice used the situation to point out that those in the news media are being targeted more severely by partisans on both sides. (We got better examples of this with the Dave Weigel Purchase Diflucan, , Octavia Nasr and Helen Thomas snafus this summer.) Also, Sanchez was one of the news industry's most popular figures on Twitter, and his account, @RickSanchezCNN, may die. Lost Remote said it's a reminder for journalists to create Twitter accounts in their own names, not just in their employers'.
Second, The New York Times' David Carr detailed a litany of examples of a frat-boy, shock-jock culture that's taken over the Tribune Co. since Sam Zell bought it in 2007. (Gawker and New York gave us punchy summaries of the revelations.) The Tribune is possibly the biggest and clearest example of the newspaper industry's disastrous decline over the past few years, low dose Diflucan, and this article simply adds more fuel to the fire. The Columbia Journalism Review's Ryan Chittum noted that the article also contains the first report of Zell directly intervening in news coverage to advance his own business interests, Purchase Diflucan. Meanwhile, the Tribune is slogging through bankruptcy, as mediation has broken down. Order Diflucan online c.o.d, —
The hyperlocal business model questioned: This week was a relatively slow one on the future-of-news front; most of the remaining stories are roundups of various interesting bits and pieces. I'll try to hit them as succinctly as possible and get you on your way. First, we talked a bit about hyperlocal news last week, and that conversation bled over into this week, as Alan Mutter talked to J-Lab's Jan Schaffer about her fantastic analysis of local news startups. Purchase Diflucan, Mutter quoted Schaffer as saying that community news sites are not a business, then went on to make the point that like many startups, many new news organizations go under within a few years. The money just isn't there, Mutter said, buy cheap Diflucan. (The Wall also has 10 takeaways from Schaffer's study.)
For those in the local news business themselves, the Reynolds Journalism Institute's Joy Mayer provided some helpful tips and anecdotes from West Seattle Blog's Tracy Record, and the Online Journalism Review's Robert Niles put together an online news startup checklist. Meanwhile, the hyperlocal giant du jour, AOL's Patch, Purchase Diflucan, continued its expansion with a launch in Seattle, and dropped hints of a plan to get into newspapers. TBD's Steve Buttry assured local news orgs that they can compete and collaborate with Patch and other competitors at the same time.
The iPad's explosive growth: It's been a little while since we heard too much about the iPad, but we got some interesting pieces about it this week, Purchase Diflucan. CNBC informed us that the iPad has blown past the DVD player as the fastest-adopted non-phone product in U.S. history with 3 million units sold in its first 80 days and 4.5 million per quarter, well more than even the iPhone's 1 million in its first quarter. It's on pace to pass the entire industries of gaming hardware and non-smart cellphones in terms of sales by next year. The NPD Group also released a survey of iPad owners that found that early adopters are using their iPads for an average of 18 hours a week, buy cheap Diflucan no rx, and for a third of them, that number is increasing. Purchase Diflucan, When the iPad first came out, many people saw its users spending that time primarily consuming media, rather than creating it. But in an attempt to refute that idea, Business Insider put together an interesting list of 10 ways people are using the iPad to create content. And marketer Hutch Carpenter looked at the quality of various uses for the iPad and predicted that as Apple and app developers improve the user's experience, it will become a truly disruptive technology. Taking Diflucan, —
More defenses of social media's social activism: Malcolm Gladwell's New Yorker piece questioning Twitter's capability of producing social change drew no shortage of criticism last week, and it continued to come in this week. Harvard scholar David Weinberger made several of the common critiques of the article, focusing on the idea that Gladwell is tearing down a straw man who believes that the web can topple tyrannies by itself. Other takes: Change Observer's Maria Popova argued Gladwell is defining activism too narrowly, and that online communities broaden our scope of empathy, which bridges the gap between awareness and action; The Guardian's Leo Mirani said that social media can quickly spread information from alternative viewpoints we might never see otherwise; and Clay Shirky, the target of much of Gladwell's broadside, seemed kind of amused by Gladwell's whole point, Purchase Diflucan.
The sharpest rebuttal this week (along with Weinberger's) came from Shea Bennett of Twittercism, who argued that change starts small and takes time, even with social media involved, but that doesn't mean it isn't happening. "As we all continue to refine and improve our online social communities, low dose Diflucan, this shift in power away from a privileged few to an increasingly organised collective that can be called at a moment’s notice [presents] a real threat to the status quo," he wrote.
Getting started with data journalism: A few cool resources on data journalism were published this week: British j-prof Paul Bradshaw wrote an invaluable guide to data journalism at The Guardian, taking you through everything from data collection to sorting to contextualizing to visualization. To Bradshaw, the craft comes down to four things: Finding data, Buy Diflucan no prescription, interrogating it, visualizing it, and mashing it. ReadWriteCloud's Alex Williams followed that post up with two posts making the case for data journalism and giving an overview of five data visualization tools. Purchase Diflucan, And if you needed some inspiration, PBS' MediaShift highlighted six incredible data visualization projects.
Reading roundup: A few more nifty things to check out this weekend:
— The bookmarking app Instapaper has become pretty popular with web/media geeks, and its founder, Marco Arment, just rolled out a paid subscription service. The Lab's Joshua Benton examined what this plan might mean for future web paywalls.
— Several mobile journalism tidbits: TBD's Steve Buttry made a case for the urgency of developing a mobile journalism plan in newsrooms, The Guardian reported on a survey looking at mobile device use and newspaper/magazine readership, and the Ryerson Review of Journalism gave an overview of Canadian news orgs' forays into mobile news.
— Northwestern j-prof Pablo Boczkowski gave a fascinating interview to the Lab's C.W. Anderson on conformity in online news, Purchase Diflucan. Must-reading for news nerds.
— Netflix founder Reed Hastings gave a talk that Ken Doctor turned into six good lessons for news organizations.
— The real hot topic of the past week in the news/tech world was not any particular social network, but The Social Network, the movie about Facebook's founding released last weekend. I couldn't bring myself to dedicate a section of this week's review to a movie, but the Lab's Megan Garber did find a way to relate it to the future of news. Enjoy.
Similar posts: Purchase Lipitor. Flagyl Mg. Purchase Cipro. Bactrim photos. Effects of Retin A. Where can i buy Synthroid online.
Trackbacks from: Purchase Diflucan. Purchase Diflucan. Purchase Diflucan. Is Diflucan safe. Diflucan dose. Diflucan pharmacy.